Ryan Zarychanski
Ryan Zarychanski is a Critical Care physician, Hematologist, and Clinician Scientist at the University of Manitoba and CancerCare Manitoba, and is an active member of the CCCTG.
Ryan Zarychanski completed combined fellowships in Critical Care Medicine and Hematology, (University of Manitoba) followed by Masters degree in Epidemiology and a research fellowship (University of Ottawa) under Drs. Dean Fergusson and Paul Hebert. Dr. Zarychanski’s research focuses on the hematologic aspects of critical illness. His major research program evaluates the efficacy and safety of unfractionated heparin in septic shock – a program that has evolved, with close collaboration from the CCCTG, into a multicentre randomized controlled trial; the HALO pilot. Other active programs of research include massive transfusion, assessment of bleeding in the ICU, and thrombocytopenia in critical illness. Methodological interests include propensity adjusted analysis and network meta-analyses. Dr. Zarychanski receives operating and salary support from the Canadian Institutes of Health Research (CIHR).